GOLD MITCHELL — SEC Form 4 filings
SEC reporting owner CIK 1242882. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-06.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2023-12-21 to 2026-08-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 95,302 shares, $1,928,954 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 37,825 shares @ $20.43 ($772,595) in ALPINE IMMUNE SCIENCES, INC., filed 2023-12-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. (ALPN) | Executive Chairman and CEO, Director | 6 | — | 5 legs · 95,302 sh · $1,928,954 | 31 |
| Attovia Therapeutics, Inc. (ATTO) | Director | 1 | — | — | 1 |
Form 4 filings — GOLD MITCHELL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-06 | 4 | Attovia Therapeutics, Inc. (ATTO) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Code (U): 2,627,157 · Disposition to issuer (D): 13,245 · Disposition to issuer (D): 96,000 · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 247,951 (derivative) · Disposition to issuer (D): 208,916 (derivative) · +6 more | EDGAR |
| 2024-05-10 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Option exercise (M): 13,245 @ $7.55 · Option exercise (M): 13,245 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/award (A): 96,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2023-12-29 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Option exercise (M): 1,016 @ $0.65 · Sale (S): 1,016 @ $20.04 · Option exercise (M): 74,441 @ $12.74 · Tax withholding (F): 48,264 @ $19.65 · Option exercise (M): 1,016 (derivative) @ $0 · Option exercise (M): 74,441 (derivative) @ $0 | EDGAR |
| 2023-12-27 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Option exercise (M): 37,825 @ $0.45 · Sale (S): 37,825 @ $20.43 · Option exercise (M): 2,402 @ $0.45 · Option exercise (M): 22,084 @ $0.65 · Sale (S): 24,486 @ $20.22 · Option exercise (M): 29,573 @ $0.65 · +5 more | EDGAR |
| 2023-12-21 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Option exercise (M): 2,402 @ $0.45 · Sale (S): 2,402 @ $20.01 · Option exercise (M): 2,402 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2023-12-20 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242882 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →